MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$37,789K
Free Cash flow
-$17,030K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Stock-based compensation expense
Accounts payable
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Proceeds from the issuance of co...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-18,916
-19,625
-50,042
-18,061
Non-cash lease expense
242
242
226
178
Stock-based compensation expense
2,703
2,731
2,071
1,825
Depreciation expense
365
380
649
1,179
Long-lived asset impairment charge
-
-
30,886
-
Net amortization of premiums and discounts on marketable securities
-1
-2
22
467
Loss on disposal of property and equipment
0
-
18
-81
Accounts receivable
0
-969
149
-876
Prepaid expenses and other current assets
399
-54
1,485
189
Accounts payable
2,105
-153
-637
-1,674
Accrued expenses and other current liabilities
-2,318
-205
1,750
-319
Deferred revenue
0
0
-322
-1,268
Operating lease liabilities
-672
-601
-1,182
-97
Other non-current assets
104
-132
-573
303
Net cash used in operating activities
-16,993
-16,074
-17,702
-17,179
Purchases of marketable securities
29,864
45,219
0
15,028
Proceeds from maturities of marketable securities
12,000
13,000
15,000
22,799
Purchases of property and equipment
37
21
84
175
Net cash (used in) provided by investing activities
-17,901
-32,240
14,916
7,596
Proceeds from the issuance of common stock in connection with the at-the-market program, net of offering costs
-21
5,041
0
0
Proceeds from the issuance of common stock and pre-funded warrants in connection with the private placement, net of offering costs
-2,896
83,154
-
-
Proceeds from exercises of stock options
0
17
380
128
Net cash provided by financing activities
-2,917
88,212
380
128
Effect of exchange rate changes on cash, cash equivalents and restricted cash
22
-25
75
-2
Net increase (decrease) in cash, cash equivalents and restricted cash
-37,789
39,873
-2,331
-9,457
Cash, cash equivalents and restricted cash, beginning of period
65,103
25,230
27,561
59,049
Cash, cash equivalents and restricted cash, end of period
27,314
65,103
25,230
27,561
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Effect of exchange rate
changes on cash, cash...
$22K
(344.44%↑ Y/Y)
Net increase
(decrease) in cash, cash...
-$37,789K
(-71.53%↓ Y/Y)
Canceled cashflow
$22K
Proceeds from maturities
of marketable...
$12,000K
(-63.53%↓ Y/Y)
Stock-based compensation
expense
$2,703K
(-28.09%↓ Y/Y)
Accounts payable
$2,105K
Depreciation expense
$365K
(-85.11%↓ Y/Y)
Non-cash lease expense
$242K
(-25.77%↓ Y/Y)
Net amortization of
premiums and discounts on...
-$1K
Net cash (used in)
provided by investing...
-$17,901K
(-183.33%↓ Y/Y)
Net cash used in
operating activities
-$16,993K
(61.10%↑ Y/Y)
Net cash provided by
financing activities
-$2,917K
(-1748.02%↓ Y/Y)
Canceled cashflow
$12,000K
Canceled cashflow
$5,416K
Purchases of marketable
securities
$29,864K
(167.57%↑ Y/Y)
Net loss
-$18,916K
(61.52%↑ Y/Y)
Proceeds from the
issuance of common stock...
-$2,896K
Proceeds from the
issuance of common stock...
-$21K
Purchases of property and
equipment
$37K
(-85.71%↓ Y/Y)
Accrued expenses and
other current...
-$2,318K
Operating lease
liabilities
-$672K
Prepaid expenses and
other current assets
$399K
Other non-current
assets
$104K
Buy us a coffee
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)